Cash flow UnitedHealth Group Inc.

Equities

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse Other stock markets 02:30:02 13/01/2026 am IST			After hours 06:30:00 am
340.51 ^USD	-1.01%		337.14	-0.99%

13/01	Health Care Down on Health-Insurance Concerns -- Health Care Roundup	DJ
13/01	Gilead's new HIV prevention shot added to CVS's drug coverage lists, CEO says	RE

45ccc858e5ef1448db05c88fb.OFPCFDrtavUh66MErDD7n1kj9vkOJUB3jncJtCQSK58.WRqvRHShLq9XpdBGnEOOyysTlclrZhMFzENK1hJAcaZ1IbBuVLlSxGeB7g

Published financial data: UNITEDHEALTH GROUP INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	20TCr	23TCr	26TCr	29TCr	31TCr
Total Interest And Dividend Income	150.2Cr	232.4Cr	203Cr	381.3Cr	449.2Cr
Gain (Loss) on Sale of Investments, Total (Rev)	-	-	-	28Cr	71Cr
Non-Insurance Activities Revenues	3.41TCr	3.44TCr	3.74TCr	4.26TCr	5.02TCr
Other Revenues, Total	2TCr	2.46TCr	2.76TCr	3.41TCr	3.6TCr
Total Revenues	26TCr	29TCr	32TCr	37TCr	40TCr
Policy Benefits	16TCr	19TCr	21TCr	24TCr	26TCr
Depreciation & Amortization - (IS) - (Collected)	289.1Cr	310.3Cr	340Cr	397.2Cr	409.9Cr
Selling General & Admin Expenses, Total	4.17TCr	4.26TCr	4.78TCr	5.46TCr	5.3TCr
Non-Insurance Activities Expenses	3.07TCr	3.1TCr	3.37TCr	3.88TCr	4.67TCr
Total Operating Expenses	23TCr	26TCr	30TCr	34TCr	37TCr
Operating Income	2.24TCr	2.4TCr	2.84TCr	3.24TCr	3.23TCr
Interest Expense, Total	-166.3Cr	-166Cr	-209.2Cr	-324.6Cr	-390.6Cr
EBT, Excl. Unusual Items	2.07TCr	2.23TCr	2.63TCr	2.91TCr	2.84TCr
Gain (Loss) on Sale of Assets	-	-	-	-	-831Cr
EBT, Incl. Unusual Items	2.07TCr	2.23TCr	2.63TCr	2.91TCr	2.01TCr
Income Tax Expense	497.3Cr	457.8Cr	570.4Cr	596.8Cr	482.9Cr
Earnings From Continuing Operations	1.58TCr	1.77TCr	2.06TCr	2.31TCr	1.52TCr
Net Income to Company	1.58TCr	1.77TCr	2.06TCr	2.31TCr	1.52TCr
Minority Interest	-37Cr	-45Cr	-52Cr	-76Cr	-84Cr
Net Income - (IS)	1.54TCr	1.73TCr	2.01TCr	2.24TCr	1.44TCr
Net Income to Common Incl Extra Items	1.54TCr	1.73TCr	2.01TCr	2.24TCr	1.44TCr
Net Income to Common Excl. Extra Items	1.54TCr	1.73TCr	2.01TCr	2.24TCr	1.44TCr
Per Share Items
Net EPS - Basic	16.23	18.33	21.47	24.12	15.64
Basic EPS - Continuing Operations	16.23	18.33	21.47	24.12	15.64
Basic Weighted Average Shares Outstanding	95Cr	94Cr	94Cr	93Cr	92Cr
Net EPS - Diluted	16.03	18.08	21.18	23.86	15.51
Diluted EPS - Continuing Operations	16.03	18.08	21.18	23.86	15.51
Diluted Weighted Average Shares Outstanding	96Cr	96Cr	95Cr	94Cr	93Cr
Normalized Basic EPS	13.27	14.31	17.02	18.78	18.35
Normalized Diluted EPS	13.11	14.12	16.78	18.58	18.19
Dividend Per Share	4.83	5.6	6.4	7.29	8.18
Payout Ratio	29.76	30.55	29.78	30.21	52.29
American Depositary Receipts Ratio (ADR)	0.01	0.01	0.01	0.01	0.01
Supplemental Items
EBITDA	2.45TCr	2.62TCr	3.08TCr	3.51TCr	3.5TCr
EBITA	2.35TCr	2.52TCr	2.97TCr	3.4TCr	3.4TCr
EBIT	2.24TCr	2.4TCr	2.84TCr	3.24TCr	3.23TCr
EBITDAR	2.56TCr	2.74TCr	3.21TCr	3.65TCr	3.64TCr
Total Revenues (As Reported)	26TCr	29TCr	32TCr	37TCr	40TCr
Effective Tax Rate - (Ratio)	23.98	20.52	21.65	20.5	24.06
Current Domestic Taxes	449Cr	393.2Cr	569.7Cr	513.4Cr	386.9Cr
Current Foreign Taxes	49Cr	52Cr	68Cr	107.9Cr	125.6Cr
Total Current Taxes	498.1Cr	444.8Cr	637.7Cr	621.3Cr	512.5Cr
Total Deferred Taxes	-80L	13Cr	-67Cr	-24Cr	-30Cr
Normalized Net Income	1.26TCr	1.35TCr	1.59TCr	1.74TCr	1.69TCr
Supplemental Operating Expense Items
Net Rental Expense, Total	110Cr	120Cr	130Cr	140Cr	140Cr
Imputed Operating Lease Interest Expense	33Cr	34Cr	40Cr	58Cr	61Cr
Imputed Operating Lease Depreciation	77Cr	86Cr	90Cr	82Cr	79Cr
Stock-Based Comp., SG&A Exp. (Total)	-	-	92Cr	105.9Cr	101.8Cr
Stock-Based Comp., Other (Total)	68Cr	80Cr	-	-	-
Total Stock-Based Compensation	68Cr	80Cr	92Cr	105.9Cr	101.8Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Total Other Investments	4.25TCr	4.38TCr	4.67TCr	4.99TCr	5.41TCr
Total investments	4.25TCr	4.38TCr	4.67TCr	4.99TCr	5.41TCr
Cash And Equivalents	1.69TCr	2.14TCr	2.34TCr	2.54TCr	2.53TCr
Reinsurance Recoverable - (IS)	-	-	-	-	-
Other Receivables - (Insurance Template)	2.54TCr	2.81TCr	3.04TCr	3.9TCr	4.85TCr
Separate Account Assets	407.6Cr	444.9Cr	408.7Cr	375.5Cr	-
Gross Property Plant And Equipment	884.6Cr	924.9Cr	1.04TCr	1.07TCr	854Cr
Accumulated Depreciation	-336.4Cr	-385.7Cr	-449.9Cr	-421Cr	-364.5Cr
Net Property Plant And Equipment	548.2Cr	539.2Cr	592.3Cr	645.7Cr	489.5Cr
Goodwill	7.13TCr	7.58TCr	9.34TCr	10TCr	11TCr
Other Intangibles, Total	1.4TCr	1.36TCr	1.86TCr	2.02TCr	2.89TCr
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	445.7Cr	532Cr	662.1Cr	608.4Cr	821.2Cr
Other Long-Term Assets, Total	1.31TCr	1.43TCr	1.66TCr	1.92TCr	2.17TCr
Total Assets	20TCr	21TCr	25TCr	27TCr	30TCr
Liabilities
Accounts Payable, Total	2.25TCr	2.46TCr	2.77TCr	3.2TCr	3.43TCr
Accrued Expenses, Total	-	-	-	-	-
Insurance And Annuity Liabilities	-	-	-	-	-
Unpaid Claims	2.19TCr	2.45TCr	2.91TCr	3.24TCr	3.42TCr
Unearned Premiums	284.2Cr	257.1Cr	307.5Cr	335.5Cr	331.7Cr
Current Portion of Long-Term Debt	352.3Cr	362Cr	231Cr	318.6Cr	324.5Cr
Current Portion of Leases	86Cr	87Cr	100Cr	103.8Cr	101.4Cr
Short-Term Borrowings	129.6Cr	-	80Cr	108.8Cr	130Cr
Long-Term Debt	3.86TCr	4.24TCr	5.45TCr	5.83TCr	7.24TCr
Long-Term Leases	358.2Cr	340.3Cr	383.3Cr	386Cr	387.5Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	1.95TCr	2.21TCr	2.53TCr	2.6TCr	2.63TCr
Deferred Tax Liability Non-Current	336.7Cr	326.5Cr	276.9Cr	302.1Cr	362Cr
Other Non Current Liabilities	873.3Cr	838.4Cr	900.6Cr	1.06TCr	1.21TCr
Total Liabilities	13TCr	14TCr	16TCr	17TCr	20TCr
Common Stock, Total	1Cr	1Cr	90L	90L	90L
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	6.93TCr	7.71TCr	8.62TCr	9.58TCr	9.6TCr
Comprehensive Income and Other	-381.4Cr	-538.4Cr	-839.3Cr	-702.7Cr	-338.7Cr
Total Common Equity	6.55TCr	7.18TCr	7.78TCr	8.88TCr	9.27TCr
Minority Interest	504.8Cr	471.9Cr	857.5Cr	1.02TCr	993.3Cr
Total Equity	7.05TCr	7.65TCr	8.63TCr	9.89TCr	10TCr
Total Liabilities And Equity	20TCr	21TCr	25TCr	27TCr	30TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	95Cr	94Cr	93Cr	92Cr	91Cr
ECS Total Common Shares Outstanding	95Cr	94Cr	93Cr	92Cr	92Cr
Book Value / Share	69.23	76.26	83.27	96.06	101.27
Tangible Book Value	-1.98TCr	-1.77TCr	-3.42TCr	-3.52TCr	-4.3TCr
Tangible Book Value Per Share	-20.98	-18.76	-36.6	-38.06	-47
Total Debt	4.79TCr	5.03TCr	6.25TCr	6.74TCr	8.18TCr
Net Debt	3.1TCr	2.89TCr	3.91TCr	4.2TCr	5.65TCr
Debt Equivalent Oper. Leases	880Cr	960Cr	1.04TCr	1.12TCr	1.12TCr
Minority Interest, Total (Incl. Fin. Div)	504.8Cr	471.9Cr	857.5Cr	1.02TCr	993.3Cr
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	53Cr	50Cr	70Cr	71Cr	36Cr
Buildings, Total	475.9Cr	488.2Cr	551.9Cr	557.3Cr	421.5Cr
Machinery, Total	355.4Cr	386.5Cr	420.6Cr	438.2Cr	396.1Cr
Full Time Employees	3L	4L	4L	4L	4L

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	1.54TCr	1.73TCr	2.01TCr	2.24TCr	1.44TCr
Depreciation, Depletion & Amortization	98Cr	98Cr	110Cr	117.2Cr	100Cr
Amortization of Goodwill and Intangible Assets - (CF)	110Cr	120Cr	130Cr	160Cr	170Cr
Total Depreciation, Depletion & Amortization	207.7Cr	218Cr	240Cr	277.2Cr	269.9Cr
Amortization of Deferred Charges, Total	81Cr	92Cr	100Cr	120Cr	140Cr
(Gain) Loss On Sale of Asset - (CF)	-	-	-	-	497.7Cr
Stock-Based Compensation (CF)	68Cr	80Cr	92Cr	105.9Cr	101.8Cr
Change in Accounts Receivable	-69Cr	-100Cr	-252.3Cr	-311.4Cr	-143.7Cr
Change in Accounts Payable	534.8Cr	116.2Cr	196.4Cr	351.6Cr	246.3Cr
Change in Unearned Revenues	28Cr	-31Cr	13Cr	20Cr	-20Cr
Change in insurance Reserves / Liabilities	15Cr	270.1Cr	405.3Cr	348.2Cr	250.3Cr
Change in Other Net Operating Assets (Collected)	-219.5Cr	-103.1Cr	-137.4Cr	-244.4Cr	-414Cr
Other Operating Activities	31Cr	-37Cr	-48Cr	1.3Cr	51Cr
Cash from Operations	2.22TCr	2.23TCr	2.62TCr	2.91TCr	2.42TCr
Capital Expenditure	-205.1Cr	-245.4Cr	-280.2Cr	-338.6Cr	-349.9Cr
Sale of Property, Plant, and Equipment	-	-	341.4Cr	68Cr	204.1Cr
Cash Acquisitions	-713.9Cr	-482.1Cr	-2.15TCr	-1.01TCr	-1.34TCr
Investment in Marketable and Equity Securities, Total	-283.6Cr	-184.3Cr	-683.7Cr	-177.7Cr	52Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-451.9Cr
Other Investing Activities, Total	-51Cr	-125.4Cr	-79Cr	-96Cr	-166.7Cr
Cash from Investing	-1.25TCr	-1.04TCr	-2.85TCr	-1.56TCr	-2.05TCr
Short Term Debt Issued, Total	87Cr	-	73Cr	1.1Cr	-
Long-Term Debt Issued, Total	486.4Cr	693.3Cr	1.48TCr	639.4Cr	1.78TCr
Total Debt Issued	573.6Cr	693.3Cr	1.56TCr	640.5Cr	1.78TCr
Short Term Debt Repaid, Total	-	-130.2Cr	-	-	-15Cr
Long-Term Debt Repaid, Total	-315Cr	-315Cr	-301.5Cr	-212.5Cr	-300Cr
Total Debt Repaid	-315Cr	-445.2Cr	-301.5Cr	-212.5Cr	-315.1Cr
Issuance of Common Stock	144Cr	135.5Cr	125.3Cr	135.3Cr	184.6Cr
Repurchase of Common Stock	-425Cr	-500Cr	-700Cr	-800Cr	-900Cr
Common Dividends Paid	-458.4Cr	-528Cr	-599.1Cr	-676.1Cr	-753.3Cr
Common & Preferred Stock Dividends Paid	-458.4Cr	-528Cr	-599.1Cr	-676.1Cr	-753.3Cr
Other Financing Activities, Total	121.8Cr	-101.1Cr	342.8Cr	-240.1Cr	-348.5Cr
Cash from Financing	-359Cr	-745.5Cr	422.6Cr	-1.15TCr	-351.2Cr
Foreign Exchange Rate Adjustments	-12Cr	-6.2Cr	3.4Cr	9.7Cr	-6.1Cr
Miscellaneous Cash Flow Adjustments	-	-	-	-	-22Cr
Net Change in Cash	593.6Cr	445.4Cr	199Cr	206.2Cr	-12Cr
Supplemental Items
Cash Interest Paid	170.4Cr	165.3Cr	194.5Cr	303.5Cr	359.4Cr
Cash Income Tax Paid (Refund)	493.5Cr	396.6Cr	522.2Cr	607.8Cr	462Cr
Net Debt Issued / Repaid	258.6Cr	248.1Cr	1.25TCr	428Cr	1.47TCr
Levered Free Cash Flow	1.92TCr	1.84TCr	2.28TCr	1.98TCr	1.16TCr
Unlevered Free Cash Flow	2.02TCr	1.94TCr	2.41TCr	2.18TCr	1.4TCr
Change In Net Working Capital	-467.6Cr	-298.8Cr	-477.5Cr	2.3Cr	778.2Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	7.55	7.32	7.76	7.79	7.06
Return on Total Capital	12.66	12.44	13.1	13.03	11.67
Return On Equity %	23.77	24.12	25.35	24.98	15.13
Return on Common Equity	25.02	25.19	26.91	26.88	15.88
Margin Analysis
Gross Profit Margin %	26.06	24.22	24.56	24.48	22.33
SG&A Margin	16.22	14.8	14.74	14.7	13.24
EBITDA Margin %	9.52	9.09	9.51	9.45	8.74
EBITA Margin %	9.14	8.75	9.17	9.14	8.49
EBIT Margin %	8.71	8.33	8.77	8.71	8.07
Income From Continuing Operations Margin %	6.13	6.17	6.37	6.23	3.81
Net Income Margin %	5.99	6.01	6.21	6.02	3.6
Net Avail. For Common Margin %	5.99	6.01	6.21	6.02	3.6
Normalized Net Income Margin	4.9	4.69	4.92	4.69	4.22
Levered Free Cash Flow Margin	7.45	6.39	7.02	5.33	2.89
Unlevered Free Cash Flow Margin	7.85	6.75	7.43	5.88	3.5
Asset Turnover
Asset Turnover	1.39	1.4	1.42	1.43	1.4
Fixed Assets Turnover	45.86	52.9	57.3	60.04	70.52
Receivables Turnover (Average Receivables)	19.21	19.42	18.6	17.31	16.66
Inventory Turnover (Average Inventory)	-	-	-	89.1	94.21
Short Term Liquidity
Current Ratio	0.69	0.73	0.73	0.75	0.83
Quick Ratio	0.62	0.66	0.65	0.69	0.75
Operating Cash Flow to Current Liabilities	0.31	0.29	0.29	0.29	0.23
Days Sales Outstanding (Average Receivables)	19.06	18.8	19.63	21.08	21.97
Days Outstanding Inventory (Average Inventory)	-	-	-	4.1	3.89
Average Days Payable Outstanding	81.87	78.29	79.03	78.96	77.99
Cash Conversion Cycle (Average Days)	-	-	-	-53.78	-52.14
Long Term Solvency
Total Debt/Equity	67.93	65.74	72.33	68.17	79.73
Total Debt / Total Capital	40.45	39.66	41.97	40.54	44.36
LT Debt/Equity	59.87	59.87	67.57	62.8	74.31
Long-Term Debt / Total Capital	35.65	36.12	39.21	37.34	41.35
Total Liabilities / Total Assets	64.25	63.96	64.86	63.86	65.61
EBIT / Interest Expense	13.47	14.44	13.59	9.97	8.27
EBITDA / Interest Expense	15.38	16.48	15.36	11.25	9.32
(EBITDA - Capex) / Interest Expense	14.15	15	14.02	10.21	8.42
Total Debt / EBITDA	1.87	1.84	1.94	1.85	2.25
Net Debt / EBITDA	1.21	1.06	1.22	1.15	1.55
Total Debt / (EBITDA - Capex)	2.04	2.02	2.13	2.03	2.49
Net Debt / (EBITDA - Capex)	1.32	1.16	1.33	1.27	1.72
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	6.19	11.84	12.71	14.64	7.71
Gross Profit, 1 Yr. Growth %	16.32	3.96	14.31	14.24	-1.71
EBITDA, 1 Yr. Growth %	12.9	6.81	17.81	13.93	-0.41
EBITA, 1 Yr. Growth %	13.63	7.08	18.14	14.2	0.09
EBIT, 1 Yr. Growth %	13.82	6.98	18.63	13.8	-0.22
Earnings From Cont. Operations, 1 Yr. Growth %	10.75	12.45	16.39	12.14	-34.14
Net Income, 1 Yr. Growth %	11.3	12.22	16.4	11.24	-35.64
Normalized Net Income, 1 Yr. Growth %	16.24	7.14	18.14	9.32	-3.05
Diluted EPS Before Extra, 1 Yr. Growth %	11.86	12.79	17.15	12.65	-35
Net Property, Plant and Equip., 1 Yr. Growth %	-4.38	-1.64	9.85	9.02	-24.19
Inventory, 1 Yr. Growth %	-	-	-	-20	35.71
Accounts Receivable, 1 Yr. Growth %	8.86	10.46	24.37	20.33	5.12
Total Assets, 1 Yr. Growth %	13.46	7.56	15.79	11.4	8.97
Common Equity, 1 Yr. Growth %	13.67	9.57	8.38	14.12	4.4
Tangible Book Value, 1 Yr. Growth %	-7.1	-11.04	93.62	2.86	22.29
Cash From Operations, 1 Yr. Growth %	20.1	0.76	17.29	10.92	-16.73
Capital Expenditures, 1 Yr. Growth %	-0.97	19.65	14.18	20.84	3.34
Levered Free Cash Flow, 1 Yr. Growth %	23.76	-8.21	18.24	-16.59	-44.5
Unlevered Free Cash Flow, 1 Yr. Growth %	22.07	-7.81	18.64	-12.85	-38.75
Dividend Per Share, 1 Yr. Growth %	16.67	15.94	14.29	13.91	12.21
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.61	8.98	12.28	13.67	11.12
Gross Profit, 2 Yr. CAGR %	11.55	9.97	9.01	14.28	5.97
EBITDA, 2 Yr. CAGR %	13.02	9.82	12.2	15.85	6.52
EBITA, 2 Yr. CAGR %	13.51	10.31	12.47	16.15	6.91
EBIT, 2 Yr. CAGR %	13.66	10.35	12.66	16.19	6.56
Earnings From Cont. Operations, 2 Yr. CAGR %	12.85	11.59	14.4	14.25	-14.06
Net Income, 2 Yr. CAGR %	13.36	11.76	14.29	13.79	-15.39
Normalized Net Income, 2 Yr. CAGR %	14.74	11.59	12.5	13.65	2.95
Diluted EPS Before Extra, 2 Yr. CAGR %	14.67	12.32	14.95	14.88	-14.43
Net Property, Plant and Equip., 2 Yr. CAGR %	-2.43	-3.02	3.94	9.43	-9.09
Inventory, 2 Yr. CAGR %	-	-	-	-	4.2
Accounts Receivable, 2 Yr. CAGR %	6.31	9.66	17.21	22.34	12.47
Total Assets, 2 Yr. CAGR %	13.84	10.47	11.6	13.57	10.18
Common Equity, 2 Yr. CAGR %	12.55	11.6	8.97	11.21	9.15
Tangible Book Value, 2 Yr. CAGR %	1.57	-9.09	31.25	41.12	12.16
Cash From Operations, 2 Yr. CAGR %	18.79	10.01	8.71	14.06	-3.9
Capital Expenditures, 2 Yr. CAGR %	-0.29	8.85	16.88	17.46	11.75
Levered Free Cash Flow, 2 Yr. CAGR %	27.39	8.96	6.62	1.46	-30.2
Unlevered Free Cash Flow, 2 Yr. CAGR %	26.21	8.33	6.9	3.77	-25.23
Dividend Per Share, 2 Yr. CAGR %	18.32	16.3	15.11	14.1	13.05
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.53	8.33	10.21	13.06	11.65
Gross Profit, 3 Yr. CAGR %	12.54	8.96	11.4	10.73	8.68
EBITDA, 3 Yr. CAGR %	13.14	10.91	12.45	12.77	10.16
EBITA, 3 Yr. CAGR %	13.43	11.33	12.86	13.05	10.53
EBIT, 3 Yr. CAGR %	13.78	11.39	13.04	13.03	10.44
Earnings From Cont. Operations, 3 Yr. CAGR %	13.37	12.72	13.17	13.64	-4.92
Net Income, 3 Yr. CAGR %	13.42	12.98	13.29	13.26	-5.89
Normalized Net Income, 3 Yr. CAGR %	14.02	12.15	13.73	11.43	7.79
Diluted EPS Before Extra, 3 Yr. CAGR %	14.35	14.04	13.91	14.18	-4.98
Net Property, Plant and Equip., 3 Yr. CAGR %	5.88	-2.17	1.09	5.61	-3.17
Accounts Receivable, 3 Yr. CAGR %	10.39	7.67	14.36	18.24	16.3
Total Assets, 3 Yr. CAGR %	12.37	11.71	12.21	11.53	12.02
Common Equity, 3 Yr. CAGR %	11.09	11.55	10.52	10.66	8.89
Tangible Book Value, 3 Yr. CAGR %	3.96	-2.82	16.97	21.01	34.54
Cash From Operations, 3 Yr. CAGR %	17.71	12.45	12.38	9.44	2.7
Capital Expenditures, 3 Yr. CAGR %	0.46	5.96	10.6	18.19	12.55
Levered Free Cash Flow, 3 Yr. CAGR %	12.45	15.9	13.71	-0.35	-15.6
Unlevered Free Cash Flow, 3 Yr. CAGR %	12.43	15.26	13.31	1.22	-11.6
Dividend Per Share, 3 Yr. CAGR %	18.88	17.52	15.63	14.71	13.46
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.36	9.24	10.01	10.43	10.57
Gross Profit, 5 Yr. CAGR %	12.59	9.93	11.11	11.05	9.19
EBITDA, 5 Yr. CAGR %	14.79	12.5	12.77	12.88	10.04
EBITA, 5 Yr. CAGR %	15.03	12.75	13.05	13.23	10.44
EBIT, 5 Yr. CAGR %	15.25	13.14	13.33	13.28	10.4
Earnings From Cont. Operations, 5 Yr. CAGR %	21.86	20.18	13.78	13.33	1.37
Net Income, 5 Yr. CAGR %	21.52	19.76	13.77	13.3	0.8
Normalized Net Income, 5 Yr. CAGR %	14.72	12.9	13.41	12.74	9.29
Diluted EPS Before Extra, 5 Yr. CAGR %	21.68	20.05	14.59	14.38	1.6
Net Property, Plant and Equip., 5 Yr. CAGR %	11.17	6.85	5.1	2.32	-3.11
Accounts Receivable, 5 Yr. CAGR %	14.56	11.76	13.07	13.32	13.6
Total Assets, 5 Yr. CAGR %	12.14	11.56	12.06	12.45	11.4
Common Equity, 5 Yr. CAGR %	14.12	13.4	10.24	11.42	9.97
Tangible Book Value, 5 Yr. CAGR %	-0.79	-2.35	14.12	12.82	15.02
Cash From Operations, 5 Yr. CAGR %	17.88	17.93	14.02	13.09	5.56
Capital Expenditures, 5 Yr. CAGR %	5.68	7.55	6.73	10.42	11.06
Levered Free Cash Flow, 5 Yr. CAGR %	15.41	9.99	11.06	10.91	-5.65
Unlevered Free Cash Flow, 5 Yr. CAGR %	15.44	9.95	11.11	11.49	-3.27
Dividend Per Share, 5 Yr. CAGR %	20.83	18.71	17.36	16.14	14.59